Jul 14, 2021 / 05:00PM GMT
Michael Higgins - Ladenburg Thalmann & Company Inc. - Analyst
Thank you. Thanks, everyone. Thanks for joining us. My name is Michael Higgins, Managing Director, senior biotech analyst here at Ladenburg Thalmann. Thanks for joining us in our Virtual Ladenburg Thalmann Healthcare Conference.
Very pleased to introduce the next company here, Eiger BioPharmaceuticals' David Cory, CEO. This is a Company I followed for a number of years, well known. As we were just discussing, David is an HDV company but a lot more going on as well.
So I will jump out of the way. If there's time at the end, have a little Q&A, but looking forward to the update. And thank you again.
David Cory - Eiger BioPharmaceuticals, Inc. - President, CEO and Business Founder
Michael, thanks very much. Appreciate the introduction and the opportunity to participate in the Ladenburg conference, as always. I will be making some forward-looking statements, and so I would just direct investors, if you have any questions, to our SEC filings.
I'll begin with our
Eiger BioPharmaceuticals Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers